Medicare Enrolled

Dr. Maha Abboud, MD FACE

Endocrinology · Melrose Park, IL
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
1835 N 19TH AVE, Melrose Park, IL 60160
7083452211
Registered in NPPES since 2006
NPI: 1346208956 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Abboud from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Abboud? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Abboud

Dr. Maha Abboud is an endocrinology specialist in Melrose Park, IL, with 20 years of NPI registration. Based on federal Medicare data, Dr. Abboud performed 1,774 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Dr. Abboud received a total of $301,864 from 25 pharmaceutical and/or device companies across 497 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Abboud is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years of NPI registration ▲ Top 29% volume in IL $301,864 industry payments

Medicare Practice Summary — 2023

Medicare Utilization ↗
1,774
Medicare services
Top 29% in IL for endocrinology
Not available
Unique patients (not deduplicated)
$58
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
842 $92 $210
Blood glucose test using hand-held instrument
A test that measures the level of sugar in the blood using a portable device. The result helps monitor blood glucose levels.
581 $3 $30
Continuous glucose monitoring with interpretation
This procedure involves monitoring blood sugar levels in tissue fluid using a sensor placed under the skin, along with the interpretation and reporting of the results.
194 $26 $80
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
106 $125 $240
New patient office visit, complex (60-74 min) 25 $136 $310
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
14 $73 $165
Continuous glucose monitoring, tissue fluid
This procedure involves continuous monitoring of blood sugar levels in tissue fluid using a sensor placed under the skin.
12 $52 $200
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.

Industry Payment Transparency

Open Payments through 2024 ↗
$301,864
Total received (2018-2024)
Avg $43,123/year across 7 years
Top 2% in IL for endocrinology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
25
Companies
497
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$14,089
2023
$16,309
2022
$15,603
2021
$22,051
2020
$20,096
2019
$105,201
2018
$108,515

Payments by company (2024)

SANOFI-AVENTIS U.S. LLC
$5,995
Novo Nordisk Inc
$5,318
Abbott Laboratories
$2,351
Novartis Pharmaceuticals Corporation
$189
Corcept Therapeutics
$152
Tandem Diabetes Care, Inc.
$31
BETA BIONICS, INC.
$24
Xeris Pharmaceuticals, Inc.
$16
Insulet Corporation
$13
Top 3 companies account for 97.0% of 2024 payments
All-time payments by company (2018-2024) ›
Novo Nordisk Inc
$99,081
Janssen Pharmaceuticals, Inc
$79,952
Amgen Inc.
$49,623
Merck Sharp & Dohme Corporation
$40,806
SANOFI-AVENTIS U.S. LLC
$14,894
AstraZeneca Pharmaceuticals LP
$12,475
Abbott Laboratories
$2,556
Insulet Corporation
$638
Dexcom, Inc.
$487
Novartis Pharmaceuticals Corporation
$429
Corcept Therapeutics
$307
AbbVie, Inc.
$119
Amarin Pharma Inc.
$115
AbbVie Inc.
$88
Xeris Pharmaceuticals, Inc.
$63
Lilly USA, LLC
$55
Tandem Diabetes Care, Inc.
$31
Horizon Therapeutics plc
$26
BETA BIONICS, INC.
$24
Allergan, Inc.
$24
ABBVIE INC.
$17
UCB, Inc.
$17
Currax Pharmaceuticals LLC
$14
DEXCOM, INC.
$12
Eisai Inc.
$12
Top 3 companies account for 75.7% of all-time payments
Associated products mentioned in payments ›
BOTOX · BYDUREON · Belviq · CONTRAVE · DEXCOM CGM · DEXCOM G6 CGM SYSTEM · DEXCOM G6 TRANSMITTER · Dexcom G6 Transmitter · ENTRESTO · ETERNA · EVENITY · FARXIGA · FREESTYLE LIBRE 3 · FreeStyle Libre · GVOKE HYPOPEN · INVOKANA · JARDIANCE · Korlym · LEQVIO · Omnipod · Ozempic · PROCLAIM · Prolia · RECORLEV · RYBELSUS · Rybelsus · STEGLATRO · SYNTHROID · Saxenda · Synthroid · TEPEZZA · TZIELD · Tresiba · Vascepa · Victoza · Wegovy · XARELTO · Xultophy 100/3.6 · ZEPBOUND · iLet Bionic Pancreas · t:slim X2 Insulin Pump with Control-IQ
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for an endocrinology specialist in Melrose Park?
Compare endocrinologists in the Melrose Park area by procedure volume, costs, and industry payment transparency.
Browse endocrinologists nearby

Geographic Context

Endocrinologists in nearby ZIP areas
226
County median income
$81,797
Nearest hospital to ZIP centroid (approximate)
LOYOLA GOTTLIEB MEMORIAL HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Abboud is a clinical cardiology specialist, with above-average Medicare volume (top 29% in IL), with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Abboud experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Abboud performed 842 office visit, established patient (30-39 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Abboud receive payments from pharmaceutical companies?
Yes. Dr. Abboud received a total of $301,864 from 25 companies across 497 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Abboud's costs compare to other endocrinologists in Melrose Park?
Dr. Abboud's average Medicare payment per service is $58. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Abboud) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →